News and Reports


Research Groups

(Cezmi Akdis)

B Cell Immunology
(Willem van de Veen)

Immune Metabolism
(Milena Sokolowska)

Immune Regulation
(Mübeccel Akdis)

Molecular Allergology
(Katja Bärenfaller)

Vaccine Development
(Claudio Rhyner)


International Networks







European Academy of Allergy and Clinical Immunology (EAACI)


Prof. Dr. Cezmi A. Akdis & Prof. Dr. Ioana Agache




Humans are exposed to a variety of toxins and chemicals every day. According to the epithelial barrier hypothesis, exposure to many of these substances damages the epithelium, the thin layer of cells that covers the surface of our skin, lungs and intestine. Defective epithelial barriers have been linked to a rise in almost two billion allergic, autoimmune, neurodegenerative and psychiatric diseases. The scientific community sees this as one of the three major threats to humanity, such as global warming and climate change, virus infection pandemic, such as COVID and Ebola.

Local epithelial damage to the skin and mucosal barriers lead to allergic conditions, inflammatory bowel disorders and celiac disease.

There is a need to continue research into the epithelial barrier to Experimental models should be developed and validated to monitor the trafficking of environmental antigens to inform approaches for the prevention, early intervention and development of novel therapies.

You can expect two exciting days with renowned scientists and interesting discussions.


Download Program


Please fill out the registration form by clicking to the button below and transfer the registration fee of CHF 220.- to the stated account. Thank you very much.

The abstract submission is still open until June, 24th 2024. The Abstract Submission Form can be downloaded here